From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
ViiV
ViiV was created in October 2009 to manage the HIV/AIDS medications of GlaxoSmithKline and Pfizer. Glaxo has an 85% ownership interest and Pfizer 15%. In 2012, Shionogi & Co. took an equity interest in the company. Like Glaxo, ViiV is based in the United Kingdom, with U.S. headquarters in Research Triangle Park, N.C.
ViiV reports payments made to physicians for speaking and consulting beginning in January 2010. In 2010, it began reporting research payments in a separate report.
See all ViiV payments, or visit ViiV's transparency page.
Notable drugs
Payment Reports
2010 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $993,776 | $3,975,102 |
| Consulting | $89,438 | $357,750 |
| $1,083,213 | $4,332,852 |
2010 Jan. to Dec. Research
| Avg. Quarterly | Total | |
|---|---|---|
| Research | $877,783 | $3,511,131 |
| $877,783 | $3,511,131 |
2011 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $722,846 | $2,891,383 |
| Consulting | $57,034 | $228,135 |
| $779,880 | $3,119,518 |
2011 Jan. to Dec. Research
| Avg. Quarterly | Total | |
|---|---|---|
| Research | $1,425,170 | $5,700,681 |
| $1,425,170 | $5,700,681 |
2012 Jan. to Sept.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $547,283 | $1,641,850 |
| Consulting | $15,500 | $46,500 |
| $562,783 | $1,688,350 |
Total Payments by State
| State | Total |
|---|---|
| California | $3,510,987 |
| New York | $2,830,305 |
| Texas | $2,645,506 |
| Florida | $1,252,676 |
| Maryland | $1,101,610 |
| Minnesota | $974,277 |
| Pennsylvania | $652,981 |
| North Carolina | $492,837 |
| Illinois | $487,436 |
| District of Columbia | $433,040 |
| Colorado | $415,264 |
| New Jersey | $386,880 |
| Georgia | $377,262 |
| Missouri | $258,241 |
| Connecticut | $237,703 |
| Arizona | $237,289 |
| Massachusetts | $200,641 |
| Michigan | $195,363 |
| North Dakota | $155,302 |
| Wisconsin | $144,603 |
| Washington | $139,152 |
| Tennessee | $134,425 |
| Alabama | $133,162 |
| Virginia | $115,482 |
| Ohio | $112,850 |
| Nevada | $104,500 |
| Rhode Island | $82,239 |
| Indiana | $73,148 |
| Idaho | $67,265 |
| Puerto Rico | $66,900 |
| Kansas | $63,070 |
| Arkansas | $62,039 |
| South Carolina | $51,722 |
| Oregon | $33,884 |
| Iowa | $32,896 |
| Mississippi | $23,874 |
| Oklahoma | $18,800 |
| Hawaii | $18,550 |
| New Mexico | $8,500 |
| Utah | $5,715 |
| Maine | $4,300 |
| Nebraska | $4,133 |
| Louisiana | $2,224 |
| New Hampshire | $2,000 |
| Kentucky | $1,500 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.
